Menin Inhibitors: The Next Frontier in AML Therapy | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Menin Inhibitors: The Next Frontier in AML Therapy | Targeted Oncolo…
1 month ago
targetedonc.com
Treatment Approaches for TP53-Mutated AML | OncLive
Treatment Approaches for TP53-Mutated AML | OncLive
Sep 9, 2021
onclive.com
Activity, Tolerability and Resistance Profile of the Menin Inhibitor Ziftomenib in Adults With Relapsed or Refractory NPM1-Mutated AML | OncLive
Activity, Tolerability and Resistance Profile of the Menin Inhibitor Zifto…
Jul 12, 2023
onclive.com
Phase 1b Study of Azacitidine, Venetoclax and Revumenib in Newly Diagnosed Older Adults with NPM1 Mutated or KMT2A Rearranged AML: Interim Results of Dose Escalation from the Beat AML Consortium | OncLive
13:50
Phase 1b Study of Azacitidine, Venetoclax and Revumenib in Ne…
Jul 23, 2024
onclive.com
QUAZAR AML-001 Trial: Prognostic Impact of NPM1 & FLT3 Mutations and MRD After Intensive Chemo and Oral-AZA Maintenance for Patients With AML in Remission
QUAZAR AML-001 Trial: Prognostic Impact of NPM1 & FLT3 Mutations …
329 viewsFeb 10, 2023
vumedi.com
Dr Fathi on Ziftomenib in R/R NPM1-Mutant AML | OncLive
Dr Fathi on Ziftomenib in R/R NPM1-Mutant AML | OncLive
Jun 28, 2023
onclive.com
Dr Wang on the Role of Menin Inhibitors in Genetically Defined AML Subtypes | OncLive
Dr Wang on the Role of Menin Inhibitors in Genetically Defined A…
Mar 26, 2025
onclive.com
Treatment Options for AML Patients with IDH2, RUNX1, or DNMT3A Mu…
Aug 8, 2022
targetedonc.com
1:29
Dr Stein on the FDA Approval of Revumenib for R/R, NPM1-Mutant …
4 months ago
onclive.com
1:20
Evaluating the use of MRD status to guide post-remission therapy in A…
1 views1 month ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
4:37
Dr. Naqvi -Groundbreaking AML updates
17 views2 months ago
YouTubeMedical Oncology Association of Southern CA
7:48
MRD as a surrogate endpoint in AML: challenges, ongoing studies…
50 views1 month ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
4:44
Dr. Gruenbaum, of Blood Cancer United, discusses menin inhibitor…
1 views4 months ago
YouTubeThe Society of Hematologic Oncology
0:48
FDA Approves Revumenib for Acute Myeloid Leukemia
13.2K views3 months ago
TikTokvescientia
Menin Inhibitor Mechanism and Patient Selection Strategies | Onc…
3 weeks ago
onclive.com
6:35
Understanding AML
176.4K viewsDec 2, 2019
YouTubeYou and AML
1:06
Day 1: The NPM1 mutation, one tiny change that can flip your blood ce…
6 months ago
TikTokmikevsaml
7:02
Acute Myeloid Leukemia (AML)
21K viewsAug 25, 2013
YouTubeNEJM Group
27:18
Acute Myelogenous Leukemia (AML) & Chronic Myelogenous Leukemi…
25.7K viewsDec 6, 2015
YouTubethe study spot
6:54
Acute Myeloid Leukemia (AML) w/ Monocytic Differentiation (formerl…
22.9K viewsMar 25, 2021
YouTubeJerad Gardner, MD
3:11
Why Is the Menin Pathway Important in AML?
Jan 30, 2023
VimeoPatient Empowerment Network
9:58
AML with NPM1 mutation
358 viewsMar 2, 2023
YouTubeAce My Path
0:54
Lorenzo Brunetti
375 viewsDec 16, 2022
YouTubeSOHO ITALY
5:40
NPM1 mutated AML
181 viewsSep 12, 2024
YouTubeHaematology, Morphology and FRCPath Exam
2:37
Protein mutation in VMD
6.8K viewsNov 21, 2018
YouTubeMohamed shehata
1:03
Personalizing AML treatment by targeting MRD mutations
122 viewsFeb 8, 2024
YouTubeVJHemOnc – Video Journal of Hematology & H…
3:08
NPM1 mutated Acute Myeloid Leukaemia
265 viewsJun 18, 2024
YouTubeHaematology, Morphology and FRCPath Exam
1:56
Minimal gene panel in AML
147 viewsJun 30, 2020
YouTubeVJHemOnc – Video Journal of Hematology & H…
7:50
Which AML patients benefit most from venetoclax treatment?
4.1K viewsFeb 17, 2022
YouTubeAML Hub
47:56
AML diagnosis and treatment 2022
18.5K viewsDec 8, 2021
YouTubeStanley Kim
See more videos
Static thumbnail place holder